中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
21期
28-29
,共2页
马来酸桂哌齐特%糖尿病%心肌缺血
馬來痠桂哌齊特%糖尿病%心肌缺血
마래산계고제특%당뇨병%심기결혈
Kelinao%Diabetes mellitus%Myocardial ischemia
目的:分析马来酸桂哌齐特治疗糖尿病合并心肌缺血疗效,为临床治疗方案选择提供参考。方法:2012年2月-2014年2月收治糖尿病合并心肌缺血患者76例,随机分为对照组和治疗组各38例,全部患者均采取改善心肌供血等常规处理及控制血糖达标,治疗组在此基础上给予马来酸桂哌齐特240 mg+5%葡萄糖溶液250 ml+诺和灵R 4 U静滴,1次/日,用药14天。观察两组临床疗效和血液动力学指标。结果:治疗组在治疗前后心电图疗效明显优于对照组。治疗组治疗后血液动力学比治疗前显著改善,明显优于对照组,差异有统计学意义(P<0.05)。结论:马来酸桂哌齐特治疗糖尿病合并心肌缺血,临床效果较满意,不良反应小,值得临床推广运用。
目的:分析馬來痠桂哌齊特治療糖尿病閤併心肌缺血療效,為臨床治療方案選擇提供參攷。方法:2012年2月-2014年2月收治糖尿病閤併心肌缺血患者76例,隨機分為對照組和治療組各38例,全部患者均採取改善心肌供血等常規處理及控製血糖達標,治療組在此基礎上給予馬來痠桂哌齊特240 mg+5%葡萄糖溶液250 ml+諾和靈R 4 U靜滴,1次/日,用藥14天。觀察兩組臨床療效和血液動力學指標。結果:治療組在治療前後心電圖療效明顯優于對照組。治療組治療後血液動力學比治療前顯著改善,明顯優于對照組,差異有統計學意義(P<0.05)。結論:馬來痠桂哌齊特治療糖尿病閤併心肌缺血,臨床效果較滿意,不良反應小,值得臨床推廣運用。
목적:분석마래산계고제특치료당뇨병합병심기결혈료효,위림상치료방안선택제공삼고。방법:2012년2월-2014년2월수치당뇨병합병심기결혈환자76례,수궤분위대조조화치료조각38례,전부환자균채취개선심기공혈등상규처리급공제혈당체표,치료조재차기출상급여마래산계고제특240 mg+5%포도당용액250 ml+낙화령R 4 U정적,1차/일,용약14천。관찰량조림상료효화혈액동역학지표。결과:치료조재치료전후심전도료효명현우우대조조。치료조치료후혈액동역학비치료전현저개선,명현우우대조조,차이유통계학의의(P<0.05)。결론:마래산계고제특치료당뇨병합병심기결혈,림상효과교만의,불량반응소,치득림상추엄운용。
Objective:To explore the therapeutic effect of kelinao in the treatment of diabetes mellitus complicated with myocardial ischemia,to provide reference for selection of clinical treatment scheme.Methods:76 cases with diabetes mellitus complicated with myocardial ischemia were selected from February 2012 to February 2014.They were randomly divided into the control group and the treatment group with 38 cases in each.All cases were treated with improving myocardial blood supply and other conventional treatment and control of blood glucose.On this basis,the treatment group were treated with kelinao 240 mg+5%glucose 250 ml+Novolin R 4U for intravenous infusion,1 time/day,for 14 days.We observed therapeutic effect and hemodynamic indexes of two groups.Results:In the treatment group,the electrocardiogram curative effect was obviously better than that of the control group.The hemodynamic examination of the treatment group was significantly improved after treatment,and it was better than the control group.The difference was statistically significant(P<0.05).Conclusion:The clinical effect of kelinao in the treatment of diabetes mellitus complicated with myocardial ischemia is satisfactory,and the adverse reaction is small,so it is worthy of clinical application.